Emcure and Gennova to resume mRNA collaboration with HDT EP News Bureau May 23, 2024 HDT has granted a license to Gennova to use HDT’s patented mRNA vaccine technology in multiple fields.
Gennova’s mRNA vaccine candidate for COVID-19 gets DCGI nod for human clinical trials EP News Bureau Dec 12, 2020 It is an indigenous mRNA vaccine candidate supported with seed grant under the Ind-CEPI mission of Department of Biotechnology of…
